99Tcm-3PRGD2 SPECT/CT分子影像在乳腺癌诊疗中的应用进展

Progress of 99Tcm-3PRGD2 SPECT/CT molecular imaging in the diagnosis and treatment of breast cancer

  • 摘要: 乳腺癌是女性发病率最高的恶性肿瘤。99Tcm-联胼尼克酰胺-3聚乙二醇-精氨酸-甘氨酸-天冬氨酸环肽二聚体(99Tcm-3PRGD2)是近年来人工合成的可用于乳腺癌分子显像的一种SPECT示踪剂。99Tcm-3PRGD2 SPECT/CT可用于早期诊断乳腺癌并进行准确的分期及分子分型,据此进行诊疗方案的选择,有助于降低患者的病死率,并提高患者的生活质量。笔者就99Tcm-3PRGD2 SPECT/CT在乳腺癌诊疗过程中的应用进展进行综述,并作出展望。

     

    Abstract: Breast cancer is the most common malignant tumor in women. 99Tcm-hydrazino-nicotinamide(HYNIC)-(poly-(ethylene glycol), PEG)4-Glu (cyclo(Arg-Gly-Asp-D-Phe-Lys(PEG4)))2 (99Tcm-3PRGD2) is a kind of artificial synthesized molecular tracer, which can be used to SPECT/CT for breast cancer imaging. 99Tcm-3PRGD2 SPECT/CT can be used for early diagnosis, accurate staging and molecular typing of the breast cancer. Selecting the treatment regimen according to the result of 99Tcm-3PRGD2 SPECT/CT is helpful to reduce the mortality of patients and improve the quality of life of patients. The application progress of 99Tcm-3PRGD2 SPECT/CT in the diagnosis of breast cancer is reviewed and prospected in this paper.

     

/

返回文章
返回